Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy
文献类型：期刊论文
| 刊名 | CHINESE MEDICAL JOURNAL
 |
| 出版日期 | 2016 |
| 卷号 | 129 |
| 关键词 | PLATINUM-BASED CHEMOTHERAPY CELL LUNG-CANCER III COLON-CANCER THYMIDYLATE SYNTHASE ADJUVANT CHEMOTHERAPY PREDICTIVE-VALUE GASTRIC-CANCER LINK REPAIR ERCC1 EXPRESSION Colorectal Cancer Excision Repair Cross-complementation Group 1 Prognosis |
| ISSN号 | 0366-6999 |
| 其他题名 | Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy |
| 英文摘要 | Background: Conflicting results about the association between expression level of excision repair cross-complementation group 1 (ERCC1) and clinical outcome in patients with colorectal cancer (CRC) receiving chemotherapy have been reported. Thus, we searched the available articles and performed the meta-analysis to elucidate the prognostic role of ERCC 1 expression in patients with CRC. |
| 资助项目 | [National High-Tech Research and Development Program of China (863 Program)] |
| 语种 | 英语 |
| CSCD记录号 | CSCD:5650420 |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/68191]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 推荐引用方式 GB/T 7714 | . Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy[J]. CHINESE MEDICAL JOURNAL,2016,129. |
| APA | (2016).Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy.CHINESE MEDICAL JOURNAL,129. |
| MLA | "Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy".CHINESE MEDICAL JOURNAL 129(2016). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。